Table 3 Concordance of E2F1 with the 70-gene signature in The Netherlands Cancer Institute data set
From: Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome
Proliferation status (E2F1) | NKI 70-gene signature prognosis | ||
|---|---|---|---|
Good | Poor | Total | |
E2F1 ≤ p30 | 4/69 (5.7%) | 6/21 (28.6%) | 10/90 (11.1%) |
E2F1 > p30 | 12/46 (26.1%) | 79/159 (49.6%) | 91/205 (44.4%) |
Total | 16/115 (13.9%) | 85/180 (47.2%) | 101/295 (34.2%) |